Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 245.00
+32.00 (15.02%)
Last updated: Apr 24, 2026, 2:17 PM HKT
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 16.76 billion as of April 23, 2026.
Market Cap
16.76B
Enterprise Value
15.41B
Revenue
648.05M
Ranking
n/a
PE Ratio
75.15
Stock Price
245.00
Market Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 16.76B, an increase of 104.41%. That is a compound annual growth rate of 309.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 16.76B | 56.62% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunshine Lake Pharma | 25.16B |
| Grand Pharmaceutical Group | 22.90B |
| The United Laboratories International Holdings | 19.73B |
| CanSino Biologics | 13.49B |
| Consun Pharmaceutical Group | 13.37B |
| Sihuan Pharmaceutical Holdings Group | 12.57B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Luye Pharma Group | 11.26B |